Double adenoma as a cause of primary hyperparathyroidism: Asymmetric hyperplasia or a distinct pathologic entity?

Am J Surg. 2021 Sep;222(3):483-489. doi: 10.1016/j.amjsurg.2021.01.021. Epub 2021 Jan 19.

Abstract

Background: Primary hyperparathyroidism (PHPT) caused by double adenoma may carry a higher risk of failure to cure. We compared outcomes in single adenoma (SA), double adenoma (DA) and four-gland hyperplasia (HP).

Methods: Patients undergoing initial parathyroidectomy for PHPT were categorized by diagnosis. The primary outcome was persistent/recurrent disease postoperatively.

Results: Of 3408 patients, 81.3% had SA, 9.5% had DA, and 9.3% had HP. Rates of persistence/recurrence were 2.9%, 5.3%, and 4.5% in SA, DA, and HP, respectively (p = 0.281). Patients with persistence/recurrence had higher preoperative calcium (11.0 vs 10.7 mg/dl, p = 0.028) and PTH (96 vs 77 pg/ml, p = 0.015), and lower rates of IOPTH normalization (77% vs 96%, p < 0.001). On multivariable analysis, DA was associated with increased risk of persistent/recurrent disease (OR 3.0, p = 0.017).

Conclusions: Most patients with DA are cured with removal of two glands, but approximately 5% experience disease persistence/recurrence. Low-normal final IOPTH was associated with lower risk of persistent/recurrent disease.

Keywords: Double adenoma; Hypercalcemia; Parathyroid hyperplasia; Primary hyperparathyroidism.

Publication types

  • Comparative Study

MeSH terms

  • Adenoma / blood
  • Adenoma / complications*
  • Adenoma / pathology
  • Adenoma / surgery
  • Aged
  • Calcium / blood
  • Female
  • Humans
  • Hypercalcemia / etiology
  • Hyperparathyroidism, Primary / blood
  • Hyperparathyroidism, Primary / epidemiology
  • Hyperparathyroidism, Primary / etiology*
  • Hyperparathyroidism, Primary / surgery
  • Hyperplasia / blood
  • Hyperplasia / epidemiology
  • Hyperplasia / pathology
  • Intraoperative Period
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Recurrence, Local / blood
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasms, Multiple Primary / blood
  • Neoplasms, Multiple Primary / complications*
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / surgery
  • Parathyroid Glands / pathology*
  • Parathyroid Glands / surgery
  • Parathyroid Hormone / blood
  • Parathyroid Neoplasms / blood
  • Parathyroid Neoplasms / complications*
  • Parathyroid Neoplasms / pathology
  • Parathyroid Neoplasms / surgery
  • Parathyroidectomy
  • Preoperative Period
  • Recurrence
  • Retrospective Studies
  • Risk
  • Treatment Outcome

Substances

  • Parathyroid Hormone
  • Calcium